Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Price-to-Tangible-Book : 4.32 (As of Jun. 17, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Chongqing Genrix Biopharmaceutical Co Price-to-Tangible-Book?

As of today (2024-06-17), Chongqing Genrix Biopharmaceutical Co's share price is ¥30.85. Chongqing Genrix Biopharmaceutical Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ¥7.14. Hence, Chongqing Genrix Biopharmaceutical Co's Price to Tangible Book Ratio of today is 4.32.

The historical rank and industry rank for Chongqing Genrix Biopharmaceutical Co's Price-to-Tangible-Book or its related term are showing as below:

SHSE:688443' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.73 Med: 4.61 Max: 5.64
Current: 4.32

During the past 5 years, Chongqing Genrix Biopharmaceutical Co's highest Price to Tangible Book Ratio was 5.64. The lowest was 3.73. And the median was 4.61.

SHSE:688443's Price-to-Tangible-Book is ranked worse than
67.8% of 1211 companies
in the Biotechnology industry
Industry Median: 2.72 vs SHSE:688443: 4.32

A closely related ratio is called PB Ratio. As of today, Chongqing Genrix Biopharmaceutical Co's share price is ¥30.85. Chongqing Genrix Biopharmaceutical Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was ¥7.25. Hence, Chongqing Genrix Biopharmaceutical Co's P/B Ratio of today is 4.25.

Chongqing Genrix Biopharmaceutical Co Price-to-Tangible-Book Historical Data

The historical data trend for Chongqing Genrix Biopharmaceutical Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Genrix Biopharmaceutical Co Price-to-Tangible-Book Chart

Chongqing Genrix Biopharmaceutical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

5.34

Chongqing Genrix Biopharmaceutical Co Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial								-	3.73	3.88	5.34	5.64

Competitive Comparison of Chongqing Genrix Biopharmaceutical Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Genrix Biopharmaceutical Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's Price-to-Tangible-Book falls into.

Chongqing Genrix Biopharmaceutical Co Price-to-Tangible-Book Calculation

Chongqing Genrix Biopharmaceutical Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	30.85	/	7.135
	=	4.32

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Chongqing Genrix Biopharmaceutical Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Chongqing Genrix Biopharmaceutical Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chongqing Genrix Biopharmaceutical Co Ltd (SHSE:688443) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan, Chongqing, CHN, 401338

Website

http://www.genrixbio.com

Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.

Executives

Jiang Ren Sheng

Director

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Headlines

No Headlines